Indications and uses
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1 or 2 tablets every 12 hours. Do not exceed 4 tablets in 24 hours. children under 12 years of age: do not use
tamper evident: do not use if carton is open or if printed seal on blister is broken or missing store between 20-25°C (68-77°F)
Drug Facts
Guaifenesin 600 mg
Expectorant
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Do not use
Ask a doctor before use if you have
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
carbomer 934P, NF; FD&C blue #1 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
Distributed by:
Reckitt Benckiser Inc.
Parsippany, NJ 07054-0224
©RBI 2009
Repackaged by:
Rebel Distributors Corp
Thousand Oaks, CA 91320
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 636522 | guaiFENesin 600 MG 12HR Extended Release Oral Tablet | PSN | 2 |
| 891301 | Mucinex Expectorant 600 MG 12HR Extended Release Oral Tablet | PSN | 2 |
| 891301 | 12 HR guaifenesin 600 MG Extended Release Oral Tablet [Mucinex] | SBD | 2 |
| 636522 | 12 HR guaifenesin 600 MG Extended Release Oral Tablet | SCD | 2 |
| 636522 | guaifenesin 600 MG 12 HR Extended Release Oral Tablet | SY | 2 |
| 891301 | Mucinex 600 MG 12 HR Extended Release Oral Tablet | SY | 2 |
| Class | Version | Type | Effective |
|---|---|---|---|
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21695-870-20 | 2019-09-24 | C162847 | 48780-1 | 934fe258-49c8-48b1-e053-8cdaa90a720a | Mucinex ® |
| 21695-870-40 | 2019-09-24 | C162847 | 48780-1 | 934fe258-49c8-48b1-e053-8cdaa90a720a | Mucinex ® |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21695-870-20 | Mucinex | 10 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 10 | 2 | |
| 21695-870-20 | Mucinex | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 2 | |
| 21695-870-40 | Mucinex | 4 in 1 CARTON | TABLET, EXTENDED RELEASE | 4 | 2 | |
| 21695-870-40 | Mucinex | 10 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 10 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Guaifenesin | ACTIVE INGREDIENT | 495W7451VQ | 2 | |
| Guaifenesin | ACTIVE MOIETY | 495W7451VQ | 2 | |
| CARBOMER 934 | INACTIVE INGREDIENT | Z135WT9208 | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 21695-870 | 21695-870-20, 21695-870-40 |
| 63824-008 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Guaifenesin | 495W7451VQ | ACTIB |
| CARBOMER 934 | Z135WT9208 | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CARBOMER 934 | CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | Z135WT9208 | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021282-001 | MUCINEX | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | |
| N021282-002 | MUCINEX | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021282-001 | MUCINEX | 600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2002-07-12 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021282-002 | MUCINEX | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2002-12-18 | 74a2ff9319b5… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021282-001 | 6372252 | 2020-04-28 | U-489 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021282-001 | 6955821 | 2020-04-28 | U-489 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021282-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021282-002 | 6372252 | 2020-04-28 | U-489 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021282-002 | 6955821 | 2020-04-28 | U-489 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021282-002 | 7838032 | 2020-04-28 | Drug product | 74a2ff9319b5… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021282-001 | 6372252 | 2020-04-28 | U-489 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021282-001 | 6955821 | 2020-04-28 | U-489 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021282-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021282-002 | 6372252 | 2020-04-28 | U-489 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021282-002 | 6955821 | 2020-04-28 | U-489 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021282-002 | 7838032 | 2020-04-28 | Drug product | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021282-001 | 6372252 | 2020-04-28 | U-489 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021282-001 | 6955821 | 2020-04-28 | U-489 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021282-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021282-002 | 6372252 | 2020-04-28 | U-489 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021282-002 | 6955821 | 2020-04-28 | U-489 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021282-002 | 7838032 | 2020-04-28 | Drug product | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021282-001 | 6372252 | 2020-04-28 | U-489 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021282-001 | 6955821 | 2020-04-28 | U-489 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021282-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021282-002 | 6372252 | 2020-04-28 | U-489 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021282-002 | 6955821 | 2020-04-28 | U-489 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021282-002 | 7838032 | 2020-04-28 | Drug product | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021282-001 | 6372252 | 2020-04-28 | U-489 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021282-001 | 6955821 | 2020-04-28 | U-489 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021282-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021282-002 | 6372252 | 2020-04-28 | U-489 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021282-002 | 6955821 | 2020-04-28 | U-489 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021282-002 | 7838032 | 2020-04-28 | Drug product | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021282-001 | 6372252 | 2020-04-28 | U-489 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021282-001 | 6955821 | 2020-04-28 | U-489 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021282-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021282-002 | 6372252 | 2020-04-28 | U-489 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021282-002 | 6955821 | 2020-04-28 | U-489 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021282-002 | 7838032 | 2020-04-28 | Drug product | ea99ee380514… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucinex | GUAIFENESIN | Reckitt Benckiser LLC | dd379cdd-90ab-42e0-ad89-f50d3220f611 | 2026-05-27 | Warnings | 63824-008 |
| fbc8717c-8980-4cab-9518-84eb732df072 | e4ac51f1-9b5e-49ad-ac79-dde6e91b65e9 | 2011-04-13 | Warnings | fbc8717c-8980-4cab-9518-84eb732df072 e4ac51f1-9b5e-49ad-ac79-dde6e91b65e9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.